{"url":"https://lda.senate.gov/api/v1/filings/33d3dee4-e6a9-4dae-8a48-618eca9a65aa/","filing_uuid":"33d3dee4-e6a9-4dae-8a48-618eca9a65aa","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2013,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/33d3dee4-e6a9-4dae-8a48-618eca9a65aa/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"WHITNEY ENGLANDER","dt_posted":"2013-10-29T15:48:50.780000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"22 WEST 27TH STREET","registrant_address_2":"5TH FLOOR","registrant_different_address":false,"registrant_city":"NEW YORK","registrant_state":"NY","registrant_zip":"10001","registrant":{"id":400852508,"url":"https://lda.senate.gov/api/v1/registrants/400852508/","house_registrant_id":41888,"name":"HARM REDUCTION COALITION","description":"national advocacy","address_1":"22 WEST 27TH STREET","address_2":"5TH FLOOR","address_3":null,"address_4":null,"city":"NEW YORK","state":"NY","state_display":"New York","zip":"10001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMIE FAVARO","contact_telephone":"+1 917-828-0293","dt_updated":"2022-04-06T16:07:42.541314-04:00"},"client":{"id":195674,"url":"https://lda.senate.gov/api/v1/clients/195674/","client_id":12,"name":"HARM REDUCTION COALITION","general_description":"national advocacy","client_government_entity":false,"client_self_select":false,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-01-01"},"lobbying_activities":[{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Overdose prevention \nSyringe exchange services\nAddiction treatment access","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55400,"prefix":null,"prefix_display":null,"first_name":"WHITNEY","nickname":null,"middle_name":null,"last_name":"ENGLANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Viral hepatitis testing and treatment access","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55400,"prefix":null,"prefix_display":null,"first_name":"WHITNEY","nickname":null,"middle_name":null,"last_name":"ENGLANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}